AKT1 and cancer: Interestingly, two “weak points” pathways, including Akt-mTOR and tight junction, were not found among the cancer essentiality pathways in [32], which highlights a distinct functional role under drug-enhanced conditions rather than an absolute necessity for survival under normal conditions.